Rising Enterprises' FDA approval for the generic pharmaceutical product identified by ANDA200824 on October 18, 2011, is expected to introduce substan...
Financial News Archive
SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
Unichem Pharmaceuticals (USA), Inc. announced the FDA approval of its oral LAMOTRIGINE generic formulation, a milestone that positions the company to ...
Quallients Pharmaceutical Health LLC received FDA approval on October 6, 2011, for the oral Gabapentin application ANDA200651, reflecting continued ma...
Sagent Pharmaceuticals has received FDA approval for the generic intramuscular injection of clindamycin phosphate, expanding its portfolio of branded ...
On September 30, 2011, Sagent Pharmaceuticals received FDA approval for ANDA090109, a move that underpins the company’s strategy to expand its product...
HIKMA announced the approval of an ANDA by the FDA on September 23, 2011, which is expected to bolster the company's generic portfolio and provide inc...
Lupin Pharmaceuticals has been granted approval by the FDA for the 50 mg oral tablets of TRAMADOL HYDROCHLORIDE, positioning the company to expand its...
Genentech, Inc. secured FDA approval today for ZELBORAF (vemurafenib), a targeted treatment for BRAF V600E mutation-positive melanoma, which is expect...
NEW YORK (Thomson Financial) - Lupin Pharmaceuticals Inc. announced Thursday that the FDA has approved its generic version of mefenamic acid tablets, ...
# FDA Approves SpecGx LLC's Generic Morphine Sulfate Oral Formulation SpecGx LLC has received FDA approval for its generic morphine sulfate oral form...
# FDA Approves Janssen Pharmaceuticals' XARELTO (Rivaroxaban) Oral Anticoagulant Janssen Pharmaceuticals, Inc. received FDA approval for XARELTO (riv...
HIKMA has received FDA approval for **[substance name]**, marking a potential addition to the company’s generic portfolio and likely providing near-te...
Fresenius Kabi USA, LLC announced the FDA approval of intravenous levothyroxine sodium, potentially resolving therapeutic gaps by offering a pre-fille...
Zyla Life Sciences US LLC has received FDA approval for OXAYDO (oxycodone hydrochloride) oral tablets, a novel formulation noted for its extended-rele...
Rising Pharma Holdings, Inc. received FDA approval on June 8, 2011, for its ANDA091604 application to market the generic version of RAMIPRIL, an oral ...
The FDA’s approval of a generic pharmaceutical from SANDOZ is poised to strengthen the company’s market presence and drive revenue growth, however, th...
On May 9, 2011, Plano Pharmaceuticals secured regulatory approval for NDA022485, a milestone that marked a significant expansion of the company’s comm...
On March 22, 2011, Actavis Labs Fl Inc received FDA approval for ANDA090084, a generic drug anticipated to drive incremental sales in the specific the...
# FDA Approves Bayer's Gadavist (Gadobutrol) for MRI Contrast Imaging Bayer HealthCare Pharmaceuticals Inc. received FDA approval for Gadavist (gadob...
PETNET Solutions, Inc. has received new approval for the ANDA079086 for Fludeoxyglucose F-18, a move that bolsters the company’s portfolio of PET imag...